Naloxone antagonizes GABAA/benzodiazepine receptor function in rat corticohippocampal synaptoneurosomes A. I. SvenssonA. BerntssonB. Söderpalm Pages: 261 - 270
The effect of gender on the melatonin suppression by light: a dose response relationship P. J. NathanE. L. WyndhamT. R. Norman Pages: 271 - 279
6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism A. StorchA. KaftanJ. Schwarz Pages: 281 - 293
Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain I. KusumiY. TakahashiT. Koyama Short Communication Pages: 295 - 302
Striatal [123I]β-CIT SPECT and prefrontal cognitive functions in Parkinson's disease U. MüllerT. WächterD. Y. von Cramon Pages: 303 - 319
CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's disease H. J. Stuerenburg Pages: 321 - 329
Glutathione S-transferase polymorphism in Parkinson's disease A. RahbarM. KempkesW. Kuhn Pages: 331 - 334
Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain M. MogiA. TogariT. Nagatsu Short Communication Pages: 335 - 341
Tryptophan degradation and immune activation in Alzheimer's disease B. WidnerF. LeblhuberD. Fuchs Pages: 343 - 353
Effects of low-level lead on glycolytic enzymes and pyruvate dehydrogenase of rat brain in vitro: relevance to sporadic Alzheimer's disease? S. W. YunS. Hoyer Pages: 355 - 368
Long-term oscillation of corticosterone following intermittent cocaine S. M. AntelmanA. R. CaggiulaD. Kocan Pages: 369 - 375
Modulation of 5-HT1A receptor mediated response by fluoxetine in rat brain M. N. SubhashB. N. SrinivasS. Jagadeesh Pages: 377 - 387